Adiponectin and Diabetes Mellitus Type 2 (Pathogenic Aspects as the Ground for Antidiabetic Pharmacotherapy Optimization)
Journal Title: Міжнародний ендокринологічний журнал - Year 2014, Vol 5, Issue 61
Abstract
The review deals with the role of adipose tissue dysfunction, primarily hypoadiponectinemia, in the development of diabetes mellitus type 2 and its cardiovascular complications. There are accentuated the benefits of oral medications, which have the rehabilitative effect on adiponectin levels in the circulation, during the formation of modern antidiabetic pharmacotherapy algorithm.
Authors and Affiliations
V. V. Роltorak, M. Yu. Gorshunska, N. S. Krasova
Keywords
Related Articles
- EP ID EP228638
- DOI -
- Views 46
- Downloads 0
Epidemiological analysis of hypothyroidism prevalence in Kharkiv region
Background. Hypothyroidism can be the cause of disorders of any organs and systems of the body. Therefore, the epidemiological analysis of hypothyroidism and the identification of the leading risk factors for its spread...
Efficacy of Early Combined Therapy with Metformin and Pioglitazone in Patients with Diabetes Mellitus Type 2
Objective. To assess the efficacy of early treatment with metformin and pioglitazone in type 2 diabetes patients. Material and methods. Twenty seven patients with decompensated type 2 diabetes mellitus treated with metfo...
Fatal Outcome in Comorbidity Aggravated by Hypoglycemia
The paper presents a fatal case after severe hypoglycemia in 45-year-old patient with comorbidity. The combination of coronary heart disease, cardiosclerosis with atrial fibrillation, complicated by heart failure III sta...
Current Trends in Pathogenesis, Diagnosis and Prognosis of Inactive Pituitary Adenomas
The paper presents an analysis of data from 138 sources in recent years. The study of factors of the development of inactive pituitary adenomas remains one of the most urgent problems of modern medicine. The development...
Studying the Efficacy of Vazonat in Comprehensive Treatment of Patients with Diabetes Mellitus Type 2
The objective — to study the effectiveness of Vazonat (meldonium) in patients with diabetes mellitus (DM) type 2 in the comparative 12-week study. Materials and methods. The study involved 55 patients with DM type 2. Pa...